A predictive approach to entrepreneurial decision making maximizes the likelihood of medical innovators’ success. But due to ...
As the broader market stages a sharp rebound from its April lows, several sectors, industries, and stocks have quietly emerged as leaders. Among them, the medical technology industry, known for its ...
The integrated system is now being used in real-world care settings and is widely available for people with type 1 diabetes ...
Baird analysts outlined stocks within medical technology where they see an upside during the second quarter’s earnings. Healthcare and med-tech has underperformed the broader market year-to-date, but ...
贝哲斯咨询统计医用气体系统市场数据显示,2025年全球医用气体系统市场规模达113.53亿元(人民币),2025年中国医用气体系统市场规模达33.71亿元。报告预估到2032年全球医用气体系统市场规模将达到161.34亿元,年复合增长率预计为5.15%。
Bochum, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Bochum Expert Nispel Presents Medical Technology Award to Japanese Companies for the First Time At the world’s largest medical technology trade fair, MEDICA ...
Med-tech companies looking for capital will have to work harder this year to attract investor attention. Even though investment firms have money to deploy, the capital will go toward more targeted ...
Med-tech companies with an AI component in their solutions will certainly find investors willing to back them. AI after all, is being used to develop more effective, smarter technologies. However, ...
Sequel Med Tech has a plan to explore a new type of ultra-concentrated and fast-acting insulin, to see how it may work with its automated pump and potentially offer a longer-lasting system for people ...
Analysts expect NeuroOne Medical Tech to report an earnings per share (EPS) of $-0.04. Anticipation surrounds NeuroOne Medical Tech's announcement, with investors hoping to hear about both surpassing ...
Abstract: Medical technologists are integral to public health, providing critical expertise in drug testing and blood banking. This article explores their role in ensuring accurate testing, ...
Investing.com-- U.S. healthcare firm Danaher Corp (NYSE: DHR) is close to a near $10 billion deal to buy medical technology company Masimo Corporation (NASDAQ: MASI ), the Financial Times reported on ...